Brielle Benyon

Patients aged 80 and older are often excluded from receiving the standard regimen for acute myeloid leukemia. However, research showed that some patients can tolerate the therapy.

Here’s a look at therapies the FDA approved in the blood cancer space over the last few months.

From Michael Richards revealing his prostate cancer diagnosis to MLB Hall-of-Famer Ryne Sandberg being cancer-free, here’s what’s happening in the oncology space this week.

In a group of breast cancer survivors, 73% who attempted pregnancy were successful, though there were certain characteristics associated with an increased chance of getting pregnant.

The Food and Drug Administration granted a breakthrough therapy designation to inavolisib plus Ibrance and fulvestrant for HR-positive, HER2-negative locally advanced or metastatic breast cancer.

An Alzheimer’s drug did not have an effect on cognitive function in breast cancer survivors. However, one researcher noted reasons why there is still hope.

From Olivia Munn opening up about undergoing a hysterectomy and egg retrieval to Michael McDonald’s learned lesson after his wife’s cancer, here’s what’s going on in the oncology space this week.

The Food and Drug Administration approved Imdelltra (tarlatamab) for the treatment of patients with advanced small cell lung cancer that progressed on or after a platinum-based chemotherapy.

The Food and Drug Administration approved Breyanzi for patients with pretreated, relapsed or refractory follicular lymphoma.

Radiation without chemotherapy was sufficient in treating locally recurrent endometrial cancer, allowing for patients to skip chemo-related side effects.

Imfinzi should be standard of care for post-chemoradiotherapy non-small cell lung cancer treatment, but some patients are not getting the drug, a study found.

The Food and Drug Administration will speed up its review of SNB-101 to treat patients with small cell lung cancer.

From Ian Gelder of “Game of Thrones” dying of cancer to Hank Green’s upcoming cancer comedy series, here’s what’s happening in the oncology space this week.

An oncology nurse discusses what patients should know before BiTE therapy, and what they can do if they do not have a social support system.

Adding Keytruda to chemotherapy with or without radiotherapy did not improve disease-free survival in newly diagnosed high-risk endometrial cancer.

The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.

Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their hospital stay.

Patients with TP53/PPM1D mutations in their stem cell product had an increased risk of myeloid neoplasms in patients with Hodgkin lymphoma undergoing autologous stem cell transplant.

From the death of author Paul Auster and musician Duane Eddy to King Charles’ visit to a cancer hospital, here’s what’s happening in the cancer space this week.

Adding Calquence to standard-of-care chemoimmunotherapy improved progression-free survival in patients with previously untreated mantle cell lymphoma.

The oncolytic virus, MEM-288 will be studied in combination with Opdivo for patients with non-small cell lung cancer that progressed on standard therapy.

An oncology nurse explained the impacts that organizations like Wonders & Worries can make on children of patients with cancer.

A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer.

The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.

From “The Young and the Restless” actress dying of cancer to “Star Trek” actress 20 years pancreatic cancer-free, here’s what’s happening in the cancer space this week.

With Carvykti now approved for pretreated myeloma, there are conversations that patients should have with their providers before treatment, a nurse said.

Patients with heavily pretreated myeloma tended to have “really amazing results” with the CAR-T cell therapy, Carvykti.

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA announced.

From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this week.

The Food and Drug Administration approved Alecensa for patients with ALK-positive non-small cell lung cancer that was surgically removed.